NALÇAKAN, H. Et Al. 2023. Computational Modeling of Novel Filgotinib Derivatives as Potent Janus Kinase (JAK1/JAK2) Inhibitors: A Detailed Molecular Docking and in-silico ADMET Analysis. 11. International Drug Chemistry Conference , (Antalya, Turkey).

NALÇAKAN, H., ÜNALAN, A. T., KURTAY, G., & SEVİN DÜZ, F., (2023). Computational Modeling of Novel Filgotinib Derivatives as Potent Janus Kinase (JAK1/JAK2) Inhibitors: A Detailed Molecular Docking and in-silico ADMET Analysis . 11. International Drug Chemistry Conference, Antalya, Turkey

NALÇAKAN, HARUN Et Al. "Computational Modeling of Novel Filgotinib Derivatives as Potent Janus Kinase (JAK1/JAK2) Inhibitors: A Detailed Molecular Docking and in-silico ADMET Analysis," 11. International Drug Chemistry Conference, Antalya, Turkey, 2023

NALÇAKAN, HARUN Et Al. "Computational Modeling of Novel Filgotinib Derivatives as Potent Janus Kinase (JAK1/JAK2) Inhibitors: A Detailed Molecular Docking and in-silico ADMET Analysis." 11. International Drug Chemistry Conference , Antalya, Turkey, 2023

NALÇAKAN, H. Et Al. (2023) . "Computational Modeling of Novel Filgotinib Derivatives as Potent Janus Kinase (JAK1/JAK2) Inhibitors: A Detailed Molecular Docking and in-silico ADMET Analysis." 11. International Drug Chemistry Conference , Antalya, Turkey.

@conferencepaper{conferencepaper, author={HARUN NALÇAKAN Et Al. }, title={Computational Modeling of Novel Filgotinib Derivatives as Potent Janus Kinase (JAK1/JAK2) Inhibitors: A Detailed Molecular Docking and in-silico ADMET Analysis}, congress name={11. International Drug Chemistry Conference}, city={Antalya}, country={Turkey}, year={2023}}